Autologous stem cell transplantation does not improve os in patients with follicular lymphoma
Wednesday, December 21, 2011 - 16:00
in Health & Medicine
High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy alone, according to an online study published December 21 in the Journal of the National Cancer Institute.